Johnson & Johnson (JNJ)
Industry Drug Manufacturers - General
This stock can be held in an Investment ISA and an Investment Account
Sell
$153.25
Buy
$153.40
$-12.59 (-7.59%)
Johnson & Johnson is a holding company, which is engaged in the research and development, manufacture and sale of products in the health care field within its Consumer, Pharmaceutical and Medical Devices segments.
Prices updated at 02 Apr 2025, 00:59 EDT
| Prices minimum 15 mins delay
|
Prices in USD
Important documents: Please ensure that you have read the Pre-sale Illustrations document & Doing Business with Fidelity document (incorporating the Fidelity Client Terms) and
- Key stats
- Price
- Fair value
- Dividends
- News
- Financials
- Valuation
- Profile
Sector
Healthcare
Industry
Drug Manufacturers - General
Chairman
Mr. Timothy Schmid
CEO
Mr. Joaquin Duato
Most recent earnings
31 Dec 2024
Fiscal year end
31 Dec 2024
Employees
139,800
Head office
One Johnson & Johnson Plaza
New Brunswick
United States
08933
Key personnel
| Owner name | Salary | Bonus | All other compensation | Total compensation | Restricted stock award |
|---|---|---|---|---|---|
Ms. Anne M. Mulcahy Independent Director | 0.17m | - | - | 0.39m | - |
Dr. John C. Reed,M.D.,PhD Executive Vice President, Innovative Medicine, R&D | 1.19m | - | - | 9.30m | - |
Ms. Marillyn A. Hewson Lead Independent Director | 0.18m | - | - | 0.41m | - |
Dr. Paula A. Johnson,M.D. Independent Director | 0.13m | - | - | 0.36m | - |
Mr. Hubert Joly Independent Director | 0.13m | - | - | 0.37m | - |
Dr. Mary C. Beckerle, PhD Independent Director | 0.15m | - | - | 0.38m | - |
Mr. Darius E. Adamczyk Independent Director | 0.13m | - | - | 0.36m | - |
Dr. Mark B. McClellan, M.D.,PhD Independent Director | 0.13m | - | - | 0.33m | - |
Mr. Joaquin Duato Chairman of the Board and Chief Executive Officer | 1.60m | - | - | 24.30m | - |
Dr. Jennifer A. Doudna, PhD Independent Director | 0.13m | - | - | 0.35m | - |
Mr. Joseph J. Wolk, C.P.A. Executive Vice President and Chief Financial Officer | 1.21m | - | - | 12.62m | - |
Mr. James D. Swanson Executive Vice President and Chief Information Officer | - | - | - | - | - |
Ms. Jennifer L. Taubert Executive Vice President and Worldwide Chairman, Innovative Medicine | 1.19m | - | - | 11.19m | - |
Ms. Kathryn E. Wengel Executive Vice President and Chief Technical Operations & Risk Officer | - | - | - | - | - |
Mr. Eugene A. Woods Independent Director | 0.13m | - | - | 0.33m | - |
Dr. Nadja Y. West, M.D. Independent Director | 0.13m | - | - | 0.35m | - |
Mr. Mark A. Weinberger Independent Director | 0.15m | - | - | 0.36m | - |
Mr. Robert J. Decker, Jr Controller and Chief Accounting Officer | - | - | - | - | - |
Ms. Vanessa Broadhurst Executive Vice President, Global Corporate Affairs | - | - | - | - | - |
Ms. Elizabeth Forminard Executive Vice President and Chief Legal Officer | - | - | - | - | - |
Mr. Timothy Schmid Executive Vice President and Worldwide Chairman, MedTech | 0.90m | - | - | 11.86m | - |
Ms. Kristen Mulholland Executive Vice President and Chief Human Resources Officer | - | - | - | - | - |
Top 5 shareholders
| Owner name | No. of shares | Share as % of port. | Last change | Portfolio % change | Date of portfolio | % Total assets |
|---|---|---|---|---|---|---|
| Vanguard Group Inc | 232,792,559 | 0.5864 | 1772706 | 0.767339 | 28 Feb 2025 | 9.66 |
| BlackRock Inc | 201,331,599 | 0.58917 | 1379117 | 0.689722 | 28 Feb 2025 | 8.35 |
| State Street Corp | 134,456,157 | 0.76708 | 210346 | 0.156687 | 28 Feb 2025 | 5.58 |
| Vanguard Investments Australia Ltd | 77,492,648 | 5.8456 | 75617 | - | 28 Feb 2025 | 3.22 |
| BlackRock Fund Advisors | 76,945,063 | 88.51541 | -3471790 | - | 28 Feb 2025 | 3.19 |
Director dealings
| Date | Action | Name | Price | Value | No. of shares | Holding (%) | Additional info |
|---|---|---|---|---|---|---|---|
| 30 Apr 2024 | - | Mr. Eugene A. Woods | 145.53 | 14,553 | 250 | - | - |
| 12 Dec 2024 | - | Mr. Mark A. Weinberger | 147.22 | 147,220 | 1,000 | - | - |
| 10 Dec 2024 | - | Ms. Marillyn A. Hewson | 149.67 | 49,990 | 11,380 | - | - |
| 10 Dec 2024 | - | Mr. Eugene A. Woods | 149.67 | 31,131 | 2,805 | - | - |
| 10 Sep 2024 | - | Ms. Marillyn A. Hewson | 165.94 | 50,114 | 10,955 | - | - |
| 10 Sep 2024 | - | Mr. Eugene A. Woods | 165.94 | 31,197 | 2,574 | - | - |
| 30 Aug 2024 | - | Mr. Robert J. Decker, Jr | 100.06 | 563,838 | 24,608 | - | - |
| 30 Aug 2024 | - | Mr. Robert J. Decker, Jr | - | - | - | - | - |
| 30 Aug 2024 | - | Mr. Robert J. Decker, Jr | 165.06 | 930,113 | 18,973 | - | - |
| 08 Jul 2024 | - | Ms. Vanessa Broadhurst | 147.16 | 738,449 | 19,834 | - | - |
| 08 Jul 2024 | - | Ms. Vanessa Broadhurst | - | - | - | - | - |
| 08 Jul 2024 | - | Ms. Vanessa Broadhurst | - | - | 24,852 | - | - |
| 04 Jun 2024 | - | Ms. Marillyn A. Hewson | 147.85 | 46,425 | 10,573 | - | - |
| 04 Jun 2024 | - | Mr. Eugene A. Woods | 147.85 | 31,196 | 2,368 | - | - |
| 17 Oct 2024 | - | Mr. Joseph J. Wolk, C.P.A. | - | - | - | - | - |
| 17 Oct 2024 | - | Mr. Joseph J. Wolk, C.P.A. | - | - | 68,835 | - | - |
| 22 May 2024 | - | Mr. Joseph J. Wolk, C.P.A. | - | - | 68,835 | - | - |
| 01 May 2024 | - | Dr. John C. Reed,M.D.,PhD | 144.59 | 1,588,177 | 14,577 | - | - |
| 01 May 2024 | - | Dr. John C. Reed,M.D.,PhD | - | - | 25,561 | - | - |
| 01 May 2024 | - | Dr. John C. Reed,M.D.,PhD | - | - | 50,510 | - | - |
Please note that past performance is not a reliable indicator of future returns.
